Keyphrases
Ionizing Radiation
100%
Anti-angiogenesis
100%
Antiangiogenesis Treatment
100%
Vascular Treatment
100%
In Vivo Antitumor Activity
100%
Combretastatin A4 Phosphate (CA4P)
100%
Irradiation
71%
Growth Delay
71%
TNP-470
57%
Cm(III)
57%
Tumor
42%
Tumor Size
42%
Tumor Growth
42%
Treatment Group
28%
Tumor Response
28%
Large Tumors
28%
Rhabdomyosarcoma
28%
Tumor Volume
14%
Statistical Significance
14%
Anesthesia
14%
Tumor Model
14%
Solid Tumors
14%
Low-rank
14%
Combination Treatment
14%
Small Tumor
14%
Tumor Blood Vessels
14%
Growth Changes
14%
Syngeneic
14%
Tubulin
14%
Rat Tumor
14%
Phosphate Treatment
14%
Size-dependent Growth
14%
Nembutal
14%
Novel Treatments
14%
Combined Therapy
14%
Antivascular Therapy
14%
INIS
tumors
100%
in vivo
100%
angiogenesis
100%
ionizing radiations
100%
growth
42%
phosphates
36%
size
26%
irradiation
26%
tnp
21%
data
10%
injection
10%
rhabdomyosarcomas
10%
doses
5%
volume
5%
combined therapy
5%
rats
5%
comparative evaluations
5%
anesthesia
5%
administration
5%
gain
5%
adults
5%
hypothesis
5%
additives
5%
blood vessels
5%
schedules
5%
solids
5%
interference
5%
nembutal
5%
Medicine and Dentistry
Neoplasm
100%
Antiangiogenic Therapy
100%
Ionizing Radiation
100%
Combretastatin A-4
53%
Picric Acid
30%
Tumor Progression
23%
Antiangiogenic Activity
15%
Rhabdomyosarcoma
15%
Treatment Group
15%
Neck
7%
Single Drug Dose
7%
Solid Malignant Neoplasm
7%
Combined Therapy
7%
Tumor Model
7%
Tubulin
7%
Vascular Tissue Neoplasm
7%
Pentobarbital
7%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Ionizing Radiation
100%
Combretastatin A4
53%
Picric Acid
30%
Tumor Growth
23%
Rhabdomyosarcoma
15%
Treatment Group
15%
Vascular Tumor
7%
Solid Malignant Neoplasm
7%
Tumor Model
7%
Tubulin
7%
Pentobarbital
7%
Wistar Albino Glaxo Rat
7%